2023 , MND, K9 Cancer Commercial Deal , Covid , Human Cancer, OHD, page-79

Close to 0 chance if you try work backwards on timelines of known paths.

Canine - Still to recruit and test 21 dogs at last comms. We know that will likely take at least 6 months if we are lucky. Then there is analysis, more actual discussions (not Rogers 'ongoing discussions') and negotiations. Realistically based on recruitment rates historically, maybe a hint of a dog deal end of 2023. Unless we manage to convince someone to cough up cash prior to completion of phase 2....but if they arent already convinced then why would they not wait until those results come out.

MND - Many more months of escalating dose protocols. Then reviewing the data. Then negotiating whether to proceed to phase 2. Then designing phase 2. Likely phase 2 commences in early 2024. Then phase 2 will take all 2024.

Others - not even on the radar.

So, unless they pull the rabbit out of the hat, there appear to be no massive inflection points between now and end of 2023. A successful MND phase 1 won't shift the dial much. I'm actually beginning to wonder if the 'reward' options were a ploy to raise a quick 700k. I'd be interested to know their reasoning for picking the option strike price. Did they actually believe it'd be there, and based on what...if they based it on their ability to drive the SP they are sadly delusional.